What is a cystosarcoma phyloda?
The rare breast tumor most commonly observed in middle -aged women is cystosarcoma philloda growth that occurs from cells forming breast tissue. Although these tumors are most commonly benign, they sometimes have the ability to grow in the surrounding structure and on distant parts of the body. The diagnosis of the tumor relies on the sample from the mass and the treatment focuses on the removal of abnormal breast tissue. Stromal breast cells are assumed that cystosarcoma tumor is formed. These cells form breast tissue and can grow and divide in response to high levels of hormones in the blood, such as estrogen or progesterone. For unknown reasons, in rare cases, these string cells may begin to multiply in an unregulated manner and can even attack the surrounding structures or spread to distant areas of the body. This unregulated growth of stromal cells causes the development of a tumor of a phyllod tumor cystosarcoma.
Risk factors for the development of phyllode cystosarcoma are misunderstood. Tumors usually appear in women in forty letech. Women who develop a tumor at a later age often have a disease that is more difficult to treat. It is known that this type of tumor is caused by a rare genetic condition known as Li-Fraumeni syndrome.
Definitive diagnosis of phillod cystosarcoma tumor relies on the acceptance of mass biopsy and control it under the microscope. The tumor itself could be detected by a breast test, a clinical breast examination licensed by a physician or mammography - a radiographic procedure used to find abnormalities in pectoral tissue. After identifying the mass, either the biopsied may be removed by removing a small part of the tumor or it can be immediately removed.
treatment of phyloda cystosarcoma focuses on its surgical removal. Breast surgery specialists carefully remove the tumor, ensure that it will remove all abnormal tumor tissue. Reseed tissue is usually sent to a pathologist who mayEzkou to the edges to ensure that the entire tumor has been removed.
The prognosis of a patient suffering from a phylodine cystosarcoma tumor depends on a number of factors. Many of these tumors are benign, which means that inherently they do not inform the surrounding structures or spread to the distant parts of the body. The prognosis in these patients is usually good, although it must be monitored for the future recurrence of the disease. If the tumor is malignant, which means it tends to spread to different areas, it is more difficult to achieve a drug from the disease. These patients may require chemotherapy or radiation therapy to be completely eradicated.